Controlled Transdermal Delivery of Dexamethasone for Pain Management via Photochemically 3D‐Printed Bioresorbable Microneedle Arrays

Abstract

AbstractMicroneedle array patches (MAPs) are extensively studied for transdermal drug delivery. Additive manufacturing enables precise control over MAP customization and rapid fabrication. However, the scope of 3D‐printable, bioresorbable materials is limited. Dexamethasone (DXM) is widely used to manage inflammation and pain, but its application is limited by systemic side effects. Thus, it is crucial to achieve high local drug concentrations while maintaining low serum levels. Here, poly(propylene fumarate‐co‐propylene succinate) oligomers are fabricated into DXM‐loaded, bioresorbable MAPs via continuous liquid interface production 3D printing. Thiol–ene click chemistry yields MAPs with tailorable mechanical and degradation properties. DXM‐loaded MAPs exhibit controlled elution of drug in vitro. Transdermal application of DXM‐loaded MAPs in a murine tibial fracture model leads to substantial relief of postoperative pain. Pharmacokinetic analysis shows that MAP administration is able to control pain at a significantly lower dose than intravenous administration. This work expands the material properties of 3D‐printed poly(propylene fumarate‐co‐propylene succinate) copolyesters and their use in drug delivery applications.